Trisomy 8, A Cytogenetic Abnormality In Myelodysplastic Syndromes, Is Constitutional Or Not?

dc.contributor.authorSaumell, Sílvia
dc.contributor.authorSolé Ristol, Francesc
dc.contributor.authorArenillas Rocha, Leonor
dc.contributor.authorMontoro, Julia
dc.contributor.authorValcárcel, David
dc.contributor.authorPedro, Carme
dc.contributor.authorSanzo, Carmen
dc.contributor.authorLuño, Elisa
dc.contributor.authorGiménez, Teresa
dc.contributor.authorArnan, Montserrat
dc.contributor.authorPomares, Helena
dc.contributor.authorPaz, Raquel de
dc.contributor.authorArrizabalaga, Beatriz
dc.contributor.authorJerez, Andrés
dc.contributor.authorMarténez, Ana B.
dc.contributor.authorSánchez Castro, Judith
dc.contributor.authorRodríguez Gambarte, Juan D.
dc.contributor.authorRaya, José María
dc.contributor.authorRíos, Eduardo
dc.contributor.authorRodríguez Rivera, María
dc.contributor.authorEspinet Solà, Blanca
dc.contributor.authorFlorensa, Lourdes
dc.date.accessioned2018-10-29T14:37:35Z
dc.date.available2018-10-29T14:37:35Z
dc.date.issued2015-06-12
dc.date.updated2018-07-24T12:30:00Z
dc.description.abstractIsolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism (cT8M). We tried to clarify the incidence of cT8M in myeloid neoplasms, specifically in MDS, and the diagnostic value of isolated +8 in MDS. Twenty-two MDS and 10 other myeloid neoplasms carrying +8 were studied. Trisomy 8 was determined in peripheral blood by conventional cytogenetics (CC) and on granulocytes, CD3+ lymphocytes and oral mucosa cells by fluorescence in situ hybridization (FISH). In peripheral blood CC, +8 was seen in 4/32 patients. By FISH, only one patient with chronic myelomonocytic leukemia showed +8 in all cell samples and was interpreted as a cT8M. In our series +8 was acquired in all MDS. Probably, once discarded cT8M by FISH from CD3+ lymphocytes and non-hematological cells, +8 should be considered with enough evidence to MDS.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid26066831
dc.identifier.urihttps://hdl.handle.net/2445/125709
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0129375
dc.relation.ispartofPLoS One, 2015, vol. 10, num. 6, p. e0129375
dc.relation.urihttps://doi.org/10.1371/journal.pone.0129375
dc.rightscc by (c) Saumell et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationLeucèmia mieloide
dc.subject.classificationLimfòcits
dc.subject.otherMyeloid leukemia
dc.subject.otherLymphocytes
dc.titleTrisomy 8, A Cytogenetic Abnormality In Myelodysplastic Syndromes, Is Constitutional Or Not?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
SaumellS.pdf
Mida:
184.85 KB
Format:
Adobe Portable Document Format